Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bengt Nilsson
Institution:
Sahlgrenska University Hospital
Observed institution:
Sahlgrenska University Hospital
ORCID:
0009-0003-0919-0656
Observed ORCID:
0009-0003-0919-0656
OpenAlex ID:
A5043335213
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
·
Clinical Cancer Research
·
36
PDF
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
2026
·
Andrea Napolitano
, Heikki Joensuu
, et al.
·
JAMA Oncology
·
5
Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
·
1
PDF
Supplementary Table S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2025
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2025
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S3 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2025
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Supplementary Figure S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2025
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2025
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Data from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Table S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Study Protocol from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S2 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S3 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S2 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Table S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial
2024
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S3 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Supplementary Figure S3 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Supplementary Figure S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Supplementary Table S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Data from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
2023
·
Heikki Joensuu
, Eva Wardelmann
, et al.
PDF
Show more works
View as search
Works count:
33
Citation count:
42
H-index:
2
I10-index:
1
Year
Topic
Type